7930
M. E. Casarini et al. / Tetrahedron 58 (2002) 7925–7932
130 (55), 117 (100), 115 (50), 91 (17), 43 (10). Anal. calcd
for C11H14N2O: C, 69.45; H, 7.42; N, 14.72. Found: C, 69.5;
H, 7.3; N, 14.7.
2 mmol of DMAB, the chalcone benzoylhydrazone 7
(0.326 g, 1 mmol) was converted to 7a (0.295 g, 90%).
1
Solid, mp 109–1118C. H NMR (CDCl3): d 4.90 (d, J¼
7.9 Hz, 1H), 6.42 (dd, J¼7.9, 15.8 Hz, 1H), 6.74 (d, J¼
15.8 Hz, 1H), 7.13–7.71 (m, 15H). IR (KBr) 1642 (CvO)
cm21. MS (EI, m/z): 328 (1, Mþ), 194 (14), 193 (100), 178
(9), 115 (44), 105 (12), 91 (11), 77 (13). Anal. calcd for
C22H20N2O: C, 80.46; H, 6.14; N, 8.53. Found: C, 80.7; H,
6.0; N, 8.3.
4.2.2. N0-(trans-2-Hexenyl)-acetohydrazide (2a). Accord-
ing to the general procedure the trans-2-hexenal aceto-
hydrazone 2 (0.154 g, 1 mmol) was converted to an
inseparable mixture of 2a (0.130 g, 83%) and 2c (0.022 g,
14%). When this reaction was scaled up and carried out
using 2.31 g of 2 (15 mmol), 2.087 g of a 85/15 mixture of
2a (76%) and 2c (13%) were secured. Solid. 1H NMR
(CDCl3): d 0.80 (t, J¼7.3 Hz, 3H), 1.28 (m, 2H), 1.72–2.08
(m, 2H), 1.85 (s, 3H), 3.28 (d, J¼6.2 Hz, 2H), 4.36 (bs, 1H),
5.22–5.68 (m, 2H), 8.72 (bs, 1H). IR (KBr) 1649 (CvO)
cm21. MS (EI, m/z): 156 (4, Mþ), 113 (11), 98 (100), 83
(21), 60 (39), 55 (74), 43 (38). HRMS. Calcd for C8H17N2O
(MþHþ): 157.1341. Found: 157.1342.
4.2.8. N0-Cyclohexyl-acetohydrazide (8c). According to
the general procedure, the 2-cyclohexenone acetohydrazone
8 (0.152 g, 1 mmol) was converted to 8c (0.132 g, 85%).
1
Solid, mp 62–648C. H NMR (CDCl3): d 0.90–1.90 (m,
10H), 1.94 (s, 3H), 2.77 (m, 1H). IR (KBr) 1641 (CvO)
cm21. MS (EI, m/z): 156 (8, Mþ), 113 (60), 98 (75), 83 (34),
71 (49), 60 (100), 55 (67), 43 (38). Anal. calcd for
C8H16N2O: C, 61.51; H, 10.32; N, 17.93. Found: C, 61.4; H,
10.5; N, 17.7.
4.2.3.
N0-(trans-2-Hexenyl)-benzoylhydrazide
(3a).
According to the general procedure the trans-2-hexenal
benzoylhydrazone 3 (0.216 g, 1 mmol) was converted to an
inseparable mixture of 3a (0.189 g, 87%) and 3c (0.018 g,
4.2.9. N0-(3-Methyl-2-cyclohexenyl)-benzoylhydrazide
(9a). According to the general procedure, the 3-methyl-2-
cyclohexenone benzoylhydrazone 9 (0.228 g, 1 mmol) was
converted to 9a (0.049 g, 21%). Solid, mp 127–1298C.
1H NMR (CDCl3): d 1.30–2.10 (m, 6H), 1.71 (s, 3H),
3.57 (m, 1H), 5.47 (m, 1H), 7.36–7.85 (m, 5H). IR (KBr)
1638 (CvO) cm21. MS (EI, m/z): 230 (2, Mþ), 137 (16),
122 (14), 110 (16), 105 (30), 95 (100), 77 (18). Anal. calcd
for C14H18N2O: C, 73.01; H, 7.88; N, 12.16. Found: C,
73.2; H, 8.0; N, 12.1. From the crude product, 0.114 g of
N0-(3-methyl-cyclohexyl)-benzoylhydrazide 9c (49%)
was also recovered. Solid, mp 133–1358C. 1H NMR
(CDCl3): d 0.94 (d, J¼6.5 Hz, 3H), 1.00–2.02 (m,
8H), 2.92 (m, 1H), 7.39–7.81 (m, 5H). IR (KBr) 1641
(CvO) cm21. MS (EI, m/z): 232 (5, Mþ), 189 (11), 122
(100), 112 (63), 105 (94), 77 (27). Anal. calcd for
C14H20N2O: C, 72.38; H, 8.68; N, 12.06. Found: C, 73.5;
H, 8.8; N, 12.0.
1
8%). Solid. H NMR (CDCl3): d 0.92 (t, J¼7.3 Hz, 3H),
1.36–1.55 (m, 2H), 2.05 (q, J¼6.9 Hz, 2H), 3.53 (d, J¼
6.2 Hz, 2H), 5.47–5.85 (m, 2H), 7.39–7.85 (5H, m). IR
(KBr) 1627 (CvO) cm21. MS (EI, m/z): 218 (2, Mþ), 175
(2), 122 (21), 105 (100), 98 (40), 77 (52). HRMS. Calcd for
C13H19N2O (MþHþ): 219.1497. Found: 219.1497.
4.2.4. N0-(2-Butenyl)-benzoylhydrazide (4a). According
to the general procedure, the crotonaldehyde benzoyl-
hydrazone 4 (0.188 g, 1 mmol) was converted to an
inseparable mixture of 4a (0.148 g, 78%) and 4c (0.029 g,
15%). Solid. 1H NMR (CDCl3): d 1.69 (dd, J¼1.1, 6.0 Hz,
3H), 3.49 (d, J¼6.4 Hz, 2H), 5.41–5.84 (m, 2H), 7.38–7.82
(m, 5H). IR (KBr) 1633 (CvO) cm21. MS (EI, m/z): 190 (2,
Mþ), 149 (4), 122 (27), 105 (100), 77 (37), 70 (41). HRMS.
Calcd for C11H15N2O (MþHþ): 191.1184. Found: 191.1186.
4.2.5. N0-(3-Methyl-2-butenyl)-benzoylhydrazide (5a).
According to the general procedure, the 3-methyl-2-butenal
benzoylhydrazone 5 (0.202 g, 1 mmol) was converted to 5a
4.3. General procedure for the 1,2-reduction of
a,b-unsaturated N,N-dimethylhydrazones with
DMAB/PTS
1
(0.200 g, 98%). Solid, mp 47–488C. H NMR (CDCl3): d
1.67 (s, 3H), 1.73 (s, 3H), 3.55 (d, J¼7.2 Hz, 2H), 5.30 (t,
J¼7.2 Hz, 1H), 7.41–7.83 (m, 5H). IR (KBr) 1628 (CvO)
cm21. MS (EI, m/z): 204 (2, Mþ), 189 (2), 136 (14), 122
(27), 105 (100), 84 (49), 77 (33), 69 (30). Anal. calcd for
C12H16N2O: C, 70.56; H, 7.89; N, 13.71. Found: C, 70.8; H,
7.7; N, 13.5.
DMAB (0.094 g, 1.6 mmol) and 1-cyclohexen-1-carbox-
aldehyde N,N-dimethylhydrazone 10 (0.152 g, 1 mmol)
were weighed in a screw capped Schlenk tube equipped
with a perforable septum; then, under argon and at 08C,
diethyl ether (2 ml) and a solution of PTS anhydrous
(1.033 g, 6 mmol) in diethyl ether (2 ml), both cooled to
08C, were added. After 3 h, the reaction mixture was
quenched with Na2CO3 (10% w/v, 6 ml), always keeping
the inert atmosphere. The organic phase (ether) was
cannulated into another Schlenk tube, evaporated and
restored as CH2Cl2 (2 ml). After cooling at 08C, triethyl-
amine (1.2 mmol) and trichloroacetyl chloride (1.1 mmol)
were introduced. The mixture, after overnight stirring, was
diluted with NaOH (5% w/v, 6 ml), and extracted with
CH2Cl2. The combined organic layers were dried over
MgSO4 and concentrated. Column chromatography of
the crude product on silica gel, using a petroleum ether
(bp 40–608C)/diethyl ether gradient, gave 0.230 g of a
89/11 mixture of trichloroacetylated 10a (69%) and 10c
(8%).
4.2.6. N0-(3-Phenyl-1-methyl-propenyl)-acetohydrazide
(6a). According to the general procedure the benzyliden-
acetone acetohydrazone 6 (0.202 g, 1 mmol) was converted
to 6a (0.188 g, 92%). Solid, mp 75–768C. 1H NMR
(CDCl3): d 1.28 (d, J¼6.5 Hz, 3H), 1.92 (s, 3H), 3.71 (m,
1H), 6.09 (dd, J¼8.0, 15.9 Hz, 1H), 6.53 (d, J¼15.9 Hz,
1H), 7.18–7.43 (m, 5H). IR (KBr) 1648 (CvO) cm21. MS
(EI, m/z): 204 (1, Mþ), 144 (11), 131 (100), 116 (9), 115 (9),
91 (28). Anal. calcd for C12H16N2O: C, 70.56; H, 7.89; N,
13.71. Found: C, 70.7; H, 8.0; N, 13.9.
4.2.7. N0-(1,3-Diphenyl-propenyl)-benzoylhydrazide
(7a). According to the general procedure, but using